|
This is a simple yet elegant means by which
virtually unlimited copies of genetic material
can be made in a test tube.
Through our long-term commitment to helping
laboratories improve the products and services
they offer, Roche Diagnostics Australia
distribute reagents and instruments used for early, rapid and accurate disease diagnosis.
We continue to build on this commitment through the development of products
using PCR technology. Since acquiring the rights to this technology in 1991, we
have made PCR the leading DNA technology in the world, enabling improved
management of patient outcomes. PCR’s exquisite sensitivity makes it possible
to diagnose infectious agents earlier and to monitor disease progression and
response to therapy. New applications of the technique will allow it to predict
disease predisposition and to individualise patient therapy, all resulting in earlier
treatment and improved patient care.
|